“An Overview of Biopharmaceutical Difficulties and Furosemide’s Bioavailability Improvement”. International Journal of Pharmaceutical Drug Design, vol. 3, no. 1, Apr. 2026, pp. 139-43, https://doi.org/10.62896/ijpdd.3.1.19.